Skip to search.
 TSX Down 0.79% TSX Ventures Down 0.04%

Novavax, Inc. (NVAX)

-NasdaqGS
4.66 Up 0.04(0.87%) Feb 10, 3:59PM EST
|After Hours : 4.60 Down 0.06 (1.29%) Feb 10, 7:41PM EST
Prev Close:4.62
Open:4.72
Bid:4.45 x 2200
Ask:5.20 x 100
1y Target Est:16.35
Beta:1.8243
Earnings Date:Feb 24 - Feb 29 (Est.)
Day's Range:4.62 - 5.01
52wk Range:4.08 - 15.01
Volume:8,151,167
Avg Vol (3m):6,890,390
Market Cap:1.26B
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NVAXUp 0.87%1.26B
MRKUp 0.75%138.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):33.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.44
Quarterly EPS Est (Dec-15) :-0.14
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback